Dyne Therapeutics, Inc. (DYN)

NASDAQ: DYN · Real-Time Price · USD

23.99

-0.31 (-1.28%)

Dec 20, 2024, 4:00 PM EST - Market closed

Dyne Therapeutics Employees

Dyne Therapeutics had 141 employees as of December 31, 2023. The number of employees increased by 22 or 18.49% compared to the previous year.

Employees

141

Change (1Y)

22

Growth (1Y)

18.49%

Revenue / Employee

n/a

Profits / Employee

-$2,088,752

Market Cap

2.44B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	141	22	18.49%
Dec 31, 2022	119	26	27.96%
Dec 31, 2021	93	46	97.87%
Dec 31, 2020	47	-	-

Related Stocks

Company Name	Employees
Select Medical Holdings	54,600
Addus HomeCare	34,846
Concentra Group Holdings Parent	9,020
Amneal Pharmaceuticals	7,700
Tandem Diabetes Care	2,400
HUTCHMED (China)	1,988
Privia Health Group	1,102
Arrowhead Pharmaceuticals	609

Employee Rankings

DYN News

5 weeks ago - Dyne Therapeutics' Q3 Preview: High-Risk, High-Reward Path In Muscle Diseases - Seeking Alpha
6 weeks ago - Dyne Therapeutics to Present at Upcoming Investor Conferences - GlobeNewsWire
6 weeks ago - The Schall Law Firm Encourages Investor Participation In An Inquiry Into Dyne Therapeutics, Inc. For Possible Securities Law Violations - Accesswire
6 weeks ago - Dyne Therapeutics Inc Is Being Investigated For Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm - Accesswire
7 weeks ago - The Schall Law Firm Encourages Investor Participation In A Case Against Dyne Therapeutics, Inc. For Securities Law Violations - Accesswire
7 weeks ago - Dyne Therapeutics Inc Is Being Sued For Securities Fraud And Shareholders With Losses Are Urged To Contact The Schall Law Firm - Accesswire
7 weeks ago - The Schall Law Firm Encourages Investors To Join A Case Against Dyne Therapeutics, Inc. For Securities Law Violations - Accesswire
7 weeks ago - Dyne Therapeutics Inc May Have Committed Securities Fraud And Stockholders With Losses Are Urged To Reach Out To The Schall Law Firm - Accesswire